Inventiva Sa (IVA)
$2.53 -$0.05 (-1.93%) 4:38 PM 12/11/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$229.75M -
Day's Range
$2.52 - $2.54 -
Volume
9,664 -
52 Week Low / High
$1.53 - $4.75 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
IVA's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 4
- Strong Buy
- 1
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong Sell
- $0.00
- Target Price
Company News
-
Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux — Jan 24th, 2024
INVENTIVA Daix (France), Long Island City (New York, United States), January 24, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients wi...
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$